Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$1,074,060.00
Apr 1, 2017
Mechanism of Ribosomal RNA Gene Silencing and Its Roles in Pluripotency and Cancer
$956,250.00
Apr 1, 2017
Stromal Gene Expression Predicts And May Drive Metastasis in Prostate Cancer
$100,000.00
Apr 1, 2017
Novel Treatments for Lysosomal Neurological Disorders: Targeting Microglia Cells and Missfolded Proteins for Therapy of Mucopolysaccharidosis IIIC
$100,000.00
Apr 1, 2017
Defining Novel Therapies for Inflammatory Bowel Disease
$416,924.00
Apr 1, 2017
Inhibiting Ice Recrystallization - A Strategy to Enable Cellular Therapies.
$696,150.00
Apr 1, 2017
Improving treatment efficacy: A randomized controlled trial of the combined used of intranasal oxytocin and cognitive behavioral therapy for the treatment of major depressive disorder
$100,000.00
Apr 1, 2017
Correction of the DMD gene with the CRISPR/Cas9 technology: restoring the reading frame and production of a dystrophin protein with an adequate structure.
$489,600.00
Apr 1, 2017
Telephone-Based Cognitive Behavioural Therapy for Post-Operative Bariatric Surgery Patients: A Randomized Controlled Trial
$959,310.00
Apr 1, 2017
Getting Ready for Vision Therapy in Peroxisome Biogenesis Disorders
$726,750.00
Apr 1, 2017
Defining the Roles of the Overgrowth Syndrome Genes NSD1, Setd2 and EZH2 in Shaping the Epigenome and Transcriptome in Early Embryonic Development